Metagenomi Therapeutics (MGX) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.78
-0.61
-0.45
-0.29

Details

Expected EPS
-0.608519
Actual EPS
-0.68
Surprise EPS
-0.07
Surprise Percent
-11.75%

Description

⁨Metagenomi Therapeutics⁩ (⁦MGX⁩) has reported earnings of ⁦-0.68⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts